BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31529350)

  • 21. Clinical, biochemical and genetic characteristics of MOGS-CDG: a rare congenital disorder of glycosylation.
    Shimada S; Ng BG; White AL; Nickander KK; Turgeon C; Liedtke KL; Lam CT; Font-Montgomery E; Lourenco CM; He M; Peck DS; Umana LA; Uhles CL; Haynes D; Wheeler PG; Bamshad MJ; Nickerson DA; Cushing T; Gates R; Gomez-Ospina N; Byers HM; ; Scalco FB; Martinez NN; Sachdev R; Smith L; Poduri A; Malone S; Harris RV; Scheffer IE; Rosenzweig SD; Adams DR; Gahl WA; Malicdan MCV; Raymond KM; Freeze HH; Wolfe LA
    J Med Genet; 2022 Jul; ():. PubMed ID: 35790351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homozygous truncating variant in
    Mahajan S; Ng BG; AlAbdi L; Earnest PDJ; Sosicka P; Patel N; Helaby R; Abdulwahab F; He M; Alkuraya FS; Freeze HH
    J Med Genet; 2023 Jul; 60(7):627-635. PubMed ID: 36357165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case report: Novel genotype of ALG2-CDG and confirmation of the heptasaccharide glycan (NeuAc-Gal-GlcNAc-Man2-GlcNAc2) as a specific diagnostic biomarker.
    Martínez Duncker I; Mata-Salgado D; Shammas I; Ranatunga W; Daniel EJP; Cruz Muñoz ME; Abreu M; Mora-Montes H; He M; Morava E; Zafra de la Rosa G
    Front Genet; 2024; 15():1363558. PubMed ID: 38770420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-mannose glycans are elevated during breast cancer progression.
    de Leoz ML; Young LJ; An HJ; Kronewitter SR; Kim J; Miyamoto S; Borowsky AD; Chew HK; Lebrilla CB
    Mol Cell Proteomics; 2011 Jan; 10(1):M110.002717. PubMed ID: 21097542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Hide and seek": Misleading transferrin variants in PMM2-CDG complicate diagnostics.
    Raynor A; Bruneel A; Vermeersch P; Cholet S; Friedrich S; Eckenweiler M; Schumann A; Hengst S; Tuncel AT; Fenaille F; Thiel C; Rymen D
    Proteomics Clin Appl; 2024 Mar; 18(2):e2300040. PubMed ID: 37876147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translational balancing questioned: Unaltered glycosylation during disulfiram treatment in mannosyl-oligosaccharide alpha-1,2-mannnosidase-congenital disorders of glycosylation (MAN1B1-CDG).
    Kemme L; Grüneberg M; Reunert J; Rust S; Park J; Westermann C; Wada Y; Schwartz O; Marquardt T
    JIMD Rep; 2021 Jul; 60(1):42-55. PubMed ID: 34258140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling a congenital disorder of glycosylation type I in C. elegans: a genome-wide RNAi screen for N-glycosylation-dependent loci.
    Struwe WB; Hughes BL; Osborn DW; Boudreau ED; Shaw KM; Warren CE
    Glycobiology; 2009 Dec; 19(12):1554-62. PubMed ID: 19729382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital disorders of glycosylation (CDG): state of the art in 2022.
    Francisco R; Brasil S; Poejo J; Jaeken J; Pascoal C; Videira PA; Dos Reis Ferreira V
    Orphanet J Rare Dis; 2023 Oct; 18(1):329. PubMed ID: 37858231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional classification of DDOST variants of uncertain clinical significance in congenital disorders of glycosylation.
    Kas SM; Mundra PA; Smith DL; Marais R
    Sci Rep; 2023 Oct; 13(1):17648. PubMed ID: 37848450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel insight into FCSK-congenital disorder of glycosylation through a CRISPR-generated cell model.
    Fazelzadeh Haghighi M; Jafari Khamirani H; Fallahi J; Monfared AA; Ashrafi Dehkordi K; Tabei SMB
    Mol Genet Genomic Med; 2024 May; 12(5):e2445. PubMed ID: 38722107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metalloglycobiology: The power of metals in regulating glycosylation.
    Durin Z; Houdou M; Legrand D; Foulquier F
    Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130412. PubMed ID: 37348823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted Proteomics Reveals Quantitative Differences in Low-Abundance Glycosyltransferases of Patients with Congenital Disorders of Glycosylation.
    Sakson R; Beedgen L; Bernhard P; Alp KM; Lübbehusen N; Röth R; Niesler B; Luzarowski M; Shevchuk O; Mayer MP; Thiel C; Ruppert T
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulated proteome and N-glycoproteome in ALG1-deficient fibroblasts.
    Budhraja R; Joshi N; Radenkovic S; Kozicz T; Morava E; Pandey A
    Proteomics; 2024 Mar; ():e2400012. PubMed ID: 38470198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Unexplained Congenital Disorder of Glycosylation-II in a Child with Neurohepatic Involvement, Hypercholesterolemia and Hypoceruloplasminemia.
    Calvo PL; Spada M; Rabbone I; Pinon M; Porta F; Cisarò F; Reggiani S; Cefalù AB; Sturiale L; Garozzo D; Lefeber DJ; Jaeken J
    JIMD Rep; 2018; 38():97-100. PubMed ID: 28643274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review.
    Maratha A; Colhoun HO; Knerr I; Coss KP; Doran P; Treacy EP
    JIMD Rep; 2017; 34():33-42. PubMed ID: 27502837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAGT1 deficiency in XMEN disease is associated with severe platelet dysfunction and impaired platelet glycoprotein N-glycosylation.
    Kauskot A; Mallebranche C; Bruneel A; Fenaille F; Solarz J; Viellard T; Feng M; Repérant C; Bordet JC; Cholet S; Denis CV; McCluskey G; Latour S; Martin E; Pellier I; Lasne D; Borgel D; Kracker S; Ziegler A; Tuffigo M; Fournier B; Miot C; Adam F
    J Thromb Haemost; 2023 Nov; 21(11):3268-3278. PubMed ID: 37207862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline
    Erger F; Aryal RP; Reusch B; Matsumoto Y; Meyer R; Zeng J; Knopp C; Noel M; Muerner L; Wenzel A; Kohl S; Tschernoster N; Rappl G; Rouvet I; Schröder-Braunstein J; Seibert FS; Thiele H; Häusler MG; Weber LT; Büttner-Herold M; Elbracht M; Cummings SF; Altmüller J; Habbig S; Cummings RD; Beck BB
    Proc Natl Acad Sci U S A; 2023 May; 120(22):e2211087120. PubMed ID: 37216524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of Rft1, a membrane protein associated with congenital disorder of glycosylation type 1N.
    Hirata E; Sakata KT; Dearden GI; Menon I; Chiduza GN; Menon AK
    bioRxiv; 2024 Apr; ():. PubMed ID: 38617304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NANS-CDG: Expanding clinical insights with a novel patient with novel variants.
    Yoo S; Cheon CK
    Am J Med Genet A; 2024 Jun; ():e63721. PubMed ID: 38822623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pseudoautosomal glycosylation disorder prompts the revision of dolichol biosynthesis.
    Wilson MP; Kentache T; Althoff CR; Schulz C; de Bettignies G; Mateu Cabrera G; Cimbalistiene L; Burnyte B; Yoon G; Costain G; Vuillaumier-Barrot S; Cheillan D; Rymen D; Rychtarova L; Hansikova H; Bury M; Dewulf JP; Caligiore F; Jaeken J; Cantagrel V; Van Schaftingen E; Matthijs G; Foulquier F; Bommer GT
    Cell; 2024 May; ():. PubMed ID: 38821050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.